Investors decided the good outweighs the bad with Danaher, says Jim Cramer

Coming into this week, I was really worried about Dan Herur, the life science and diagnostic powerhouse to be on for the travel trust. You can follow, of course, by joining the CBC Investing Club. See, for many years, Danner was arguably the bestrun conglomerate on Earth.And the stock has been a phenomenal long-term winner, up over 1,000% over the past 20 years. But ever since we got through the pandemic, the stock has struggled to get back on track. Now, we bought this one in early 2022.We happened to own ...